Co-D Therapeutics Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $428K
Latest Deal Amount
  • Investors
  • 2

Co-D Therapeutics General Information

Description

Operator of a preclinical stage biopharmaceutical company intended to develop combination nano-medicines with high safety profiles to treat cancer. The company's drugs are based on a polymeric micelle delivery system that eliminates toxic carriers, permits safe dose-escalation, and facilitates multi-drug delivery, enabling physicians to treat in an enhanced way.

Contact Information

Website
www.co-drx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 821 East Washington Avenue
  • Suite 200
  • Madison, WI 53703
  • United States
+1 (608) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Co-D Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 08-Nov-2018 $428K 00000 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Co-D Therapeutics’s complete valuation and funding history, request access »

Co-D Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Glen Kwon Ph.D Co-Founder, Chief Scientific Officer, Board Member & Advisor
Kevin Kozak Ph.D Co-Founder, Chief Medical Officer, Board Member & Advisor
You’re viewing 2 of 3 executive team members. Get the full list »

Co-D Therapeutics Board Members (3)

Name Representing Role Since
Alex Kim Self Board Member 000 0000
Patrick Genn Co-D Therapeutics Board Member 000 0000
Paul Radspinner Wisconsin Economic Development Corporation Board Member 000 0000
To view Co-D Therapeutics’s complete board members history, request access »

Co-D Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Co-D Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Wisconsin Economic Development Corporation Government Minority 000 0000 000000 0
Wisconsin Alumni Research Foundation Venture Capital Minority 000 0000 000000 0
To view Co-D Therapeutics’s complete investors history, request access »